Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
British Journal of Pharmacology|January 1, 1978
alpha-Adrenoceptors in the mouse vas deferens and their effects on its response to electrical stimulationI Marshall, P A Nasmyth, C G Nicholl, et al.British Journal of Pharmacology|May 1, 1984
An investigation into the selectivity of a novel series of benzoquinolizines for alpha 2-adrenoceptors in vivoP M Paciorek, V Pierce, N B Shepperson, et al.Journal of Experimental Child Psychology|October 1, 1990
Induction from a single instance: formation of a novel categoryJ F Macario, E F Shipley, D O BillmanBritish Journal of Pharmacology|February 1, 1986
Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoraminV Pierce, N B Shepperson, M H Todd, et al.Biochemical Pharmacology|March 1, 1991
The atriopeptidase inhibitor (+/-) candoxatrilat reduces the clearance of atrial natriuretic factor in both intact and nephrectomized rats: evidence for an extrarenal site of actionP L Barclay, J A Bennett, G M Samuels, et al.Clinical Science (London, England : 1979)|March 1, 1991
Inhibition of neutral endopeptidase (EC 3.4.24.11) leads to an atrial natriuretic factor-mediated natriuretic, diuretic and antihypertensive response in rodentsN B Shepperson, P L Barclay, J A Bennett, et al.Journal of Cardiovascular Pharmacology|April 1, 1989
Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitorC Ennis, S E Granger, V C Middlefell, et al.European Journal of Pharmacology|April 16, 1986
Cardiovascular effects of human and rat CGRP compared in the rat and other speciesI Marshall, S J Al-Kazwini, P M Roberts, et al.Biochemical Pharmacology|September 25, 1992
The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockadeP L Barclay, J A Bennett, P M Greengrass, et al.Journal of Medicinal Chemistry|February 1, 1990
Design of an antithrombotic-antihypertensive agent (Wy 27569). Synthesis and evaluation of a series of 2-heteroaryl-substituted dihydropyridinesJ L Archibald, G Bradley, A Opalko, et al.Pageof 4